受强制性开放获取政策约束的文章 - Jeremy Shapiro了解详情
无法在其他位置公开访问的文章：4 篇
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ...
The lancet Gastroenterology & hepatology 3 (4), 263-270, 2018
强制性开放获取政策： Canadian Cancer Society
Current opinion on optimal treatment for colorectal cancer
TJ Price, E Segelov, M Burge, DG Haller, SP Ackland, NC Tebbutt, ...
Expert review of anticancer therapy 13 (5), 597-611, 2013
强制性开放获取政策： UK Medical Research Council
Cetuximab alone or with irinotecan for resistant KRAS-, NRAS-, BRAF-and PIK3CA-wild-type metastatic colorectal cancer: the AGITG randomized phase II ICECREAM study
JD Shapiro, S Thavaneswaran, CR Underhill, KP Robledo, CS Karapetis, ...
Clinical colorectal cancer 17 (4), 313-319, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
The association of health-care contact days with physical function and survival in CCTG/AGITG CO. 17
A Gupta, CJ O’Callaghan, L Zhu, DJ Jonker, RPW Wong, B Colwell, ...
JNCI: Journal of the National Cancer Institute, djae077, 2024
强制性开放获取政策： Arnold Ventures LLC
可在其他位置公开访问的文章：25 篇
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ...
Journal of Clinical Oncology 38 (32), 3763-3772, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang, S Kosmider, R Wong, ...
New England Journal of Medicine 386 (24), 2261-2272, 2022
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 …
W Abida, D Campbell, A Patnaik, JD Shapiro, B Sautois, NJ Vogelzang, ...
Clinical Cancer Research 26 (11), 2487-2496, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17
CS Karapetis, D Jonker, M Daneshmand, JE Hanson, CJ O'Callaghan, ...
Clinical Cancer Research 20 (3), 744-753, 2014
强制性开放获取政策： Canadian Cancer Society, Ontario Institute for Cancer Research
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
DJ Jonker, CS Karapetis, C Harbison, CJ O'Callaghan, D Tu, RJ Simes, ...
British journal of cancer 110 (3), 648-655, 2014
强制性开放获取政策： Canadian Cancer Society
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ...
Journal of Clinical Oncology 41 (11), 2007-2019, 2023
强制性开放获取政策： US National Institutes of Health, Health Research Board, Ireland, Cancer …
Fc-γ receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO. 17 trial of colorectal cancer
G Liu, D Tu, M Lewis, D Cheng, LA Sullivan, Z Chen, E Morgen, J Simes, ...
Clinical Cancer Research 22 (10), 2435-2444, 2016
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Rucaparib for the treatment of metastatic castration-resistant prostate cancer associated with a DNA damage repair gene alteration: final results from the phase 2 TRITON2 study
W Abida, D Campbell, A Patnaik, AH Bryce, J Shapiro, RM Bambury, ...
European urology 84 (3), 321-330, 2023
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Emergence of BRCA reversion mutations in patients with metastatic castration-resistant prostate cancer after treatment with rucaparib
A Loehr, A Hussain, A Patnaik, AH Bryce, D Castellano, A Font, J Shapiro, ...
European urology 83 (3), 200-209, 2023
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Evaluating the time toxicity of cancer treatment in the CCTG CO. 17 trial
A Gupta, CJ O'Callaghan, L Zhu, DJ Jonker, RPW Wong, B Colwell, ...
JCO Oncology Practice 19 (6), e859-e866, 2023
强制性开放获取政策： Canadian Cancer Society
Quality of life in patients with K‐RAS wild‐type colorectal cancer: The CO.20 Phase 3 Randomized Trial
J Ringash, HJ Au, LL Siu, JD Shapiro, DJ Jonker, JR Zalcberg, MJ Moore, ...
Cancer 120 (2), 181-189, 2014
强制性开放获取政策： Canadian Cancer Society
Response to rucaparib in BRCA-mutant metastatic castration-resistant prostate cancer identified by genomic testing in the TRITON2 study
A Loehr, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ...
Clinical Cancer Research 27 (24), 6677-6686, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
A randomized phase III study of napabucasin [BBI608](NAPA) vs placebo (PBO) in patients (pts) with pretreated advanced colorectal cancer (ACRC): the CCTG/AGITG CO. 23 trial
DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ...
Annals of Oncology 27, vi150, 2016
强制性开放获取政策： Canadian Cancer Society
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
ID Davis, A Long, S Yip, D Espinoza, JF Thompson, G Kichenadasse, ...
Annals of Oncology 26 (6), 1118-1123, 2015
强制性开放获取政策： National Health and Medical Research Council, Australia
318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II …
J Tie, J Cohen, K Lahouel, SN Lo, Y Wang, R Wong, J Shapiro, S Harris, ...
Annals of Oncology 33, S683, 2022
强制性开放获取政策： US National Institutes of Health
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
A Roohullah, HL Wong, KM Sjoquist, P Gibbs, K Field, B Tran, J Shapiro, ...
World Journal of Gastroenterology: WJG 21 (17), 5352, 2015
强制性开放获取政策： National Health and Medical Research Council, Australia
出版信息和资助信息由计算机程序自动确定